BREYANZI
Live / Registered — Registered (as of 30 Aug 2022)
What this means for you
Registered since 30 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88569196
- Registration number
- 6834335
- Mark type
- Design + words
- Filed
- 07 Aug 2019
- Published for opposition
- 22 Oct 2019
- Registered
- 30 Aug 2022
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
Owner
- JUNO THERAPEUTICS, INC., SEATTLE, WA, US
- JUNO THERAPEUTICS, INC., SEATTLE, WA, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 30 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 26 Jul 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Jul 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jun 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Jun 2022 — USE AMENDMENT FILED
- 15 Jun 2022 — TEAS STATEMENT OF USE RECEIVED
- 14 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2021 — SOU EXTENSION 4 GRANTED
- 10 Dec 2021 — SOU EXTENSION 4 FILED
- 10 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2021 — SOU EXTENSION 3 GRANTED
- 16 Jun 2021 — SOU EXTENSION 3 FILED
- 16 Jun 2021 — SOU TEAS EXTENSION RECEIVED